Literature DB >> 30570275

Examining the neurochemical underpinnings of animal models of risky choice: Methodological and analytic considerations.

Justin R Yates1.   

Abstract

Because risky choice is associated with several psychiatric conditions, recent research has focused on examining the underlying neurochemical processes that control risk-based decision-making. Not surprisingly, several tasks have been developed to study the neural mechanisms involved in risky choice. The current review will briefly discuss the major tasks used to measure risky choice and will summarize the contribution of several major neurotransmitter systems to this behavior. To date, the most common measures of risky choice are the probability discounting task, the risky decision task, and the rat gambling task. Across these three tasks, the contribution of the dopaminergic system has been most studied, although the effects of serotonergic, adrenergic, cholinergic, and glutamatergic ligands will be discussed. Drug effects across these tasks have been inconsistent, which makes determining the precise role of neurotransmitter systems in risky choice somewhat difficult. Furthermore, procedural differences can modulate drug effects in these procedures, and the way data are analyzed can alter the interpretations one makes concerning pharmacological manipulations. By taking these methodological/analytic considerations into account, we may better elucidate the neurochemistry of risky decision-making. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30570275      PMCID: PMC6467223          DOI: 10.1037/pha0000239

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  5 in total

1.  Group I metabotropic glutamate receptor antagonists impair discriminability of reinforcer magnitude, but not risky choice, in a probability-discounting task.

Authors:  Justin R Yates; Marissa R Chitwood; Karson E Evans; Joy L Kappesser; Christopher P Murray; Tatiana A Paradella-Bradley; Brett T Torline
Journal:  Behav Brain Res       Date:  2019-03-01       Impact factor: 3.332

2.  Effects of the psychoactive compounds in green tea on risky decision-making.

Authors:  Anna E Liley; Haleigh N Joyner; Daniel B K Gabriel; Nicholas W Simon
Journal:  Behav Pharmacol       Date:  2022-02-01       Impact factor: 2.293

3.  Effects of 5-HT2C, 5-HT1A receptor challenges and modafinil on the initiation and persistence of gambling behaviours.

Authors:  Trevor Humby; Georgia E Smith; Rebecca Small; William Davies; Jenny Carter; Chloe A Bentley; Catharine A Winstanley; Robert D Rogers; Lawrence S Wilkinson
Journal:  Psychopharmacology (Berl)       Date:  2020-03-02       Impact factor: 4.530

4.  Risk-Based Decision Making: A Systematic Scoping Review of Animal Models and a Pilot Study on the Effects of Sleep Deprivation in Rats.

Authors:  Cathalijn H C Leenaars; Stevie Van der Mierden; Ruud N J M A Joosten; Marnix A Van der Weide; Mischa Schirris; Maurice Dematteis; Franck L B Meijboom; Matthijs G P Feenstra; André Bleich
Journal:  Clocks Sleep       Date:  2021-01-20

5.  Differential effects of glutamate N-methyl-D-aspartate receptor antagonists on risky choice as assessed in the risky decision task.

Authors:  Justin R Yates; Matthew J Horchar; Alexis L Ellis; Joy L Kappesser; Prodiges Mbambu; Tanner G Sutphin; Destiny S Dehner; Hephzibah O Igwe; Makayla R Wright
Journal:  Psychopharmacology (Berl)       Date:  2020-09-16       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.